# Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer

> **NCT01303419** · NA · TERMINATED · sponsor: **GE Healthcare** · enrollment: 224 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** CE-BMRI
- **DEVICE:** DE-CEDM

## Key facts

- **NCT ID:** NCT01303419
- **Lead sponsor:** GE Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04
- **Primary completion:** 2012-06-30
- **Final completion:** 2012-06-30
- **Target enrollment:** 224 (ACTUAL)
- **Why stopped:** Sponsor determined there was sufficient material collected to answer the study questions.
- **Last updated:** 2019-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01303419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01303419, "Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01303419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*